dockets: FDA-2025-P-7432
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-P-7432 | FDA | Requests that FDA declare that Guanfacine Extended-Release Powder for Oral Suspension, 1 mg/mL, is suitable for submission as an ANDA | Nonrulemaking | 2026-06-22T18:25:03Z | 0b000064b91141ce | list_pull |
Links from other tables
- 7 rows from docket_id in documents